Establishment Labs Holdings Current Ratio 2017-2023 | ESTA
Establishment Labs Holdings current ratio from 2017 to 2023. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Establishment Labs Holdings Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2023-12-31 | $0.18B | $0.06B | 3.06 |
| 2023-09-30 | $0.19B | $0.05B | 3.71 |
| 2023-06-30 | $0.21B | $0.04B | 4.83 |
| 2023-03-31 | $0.14B | $0.04B | 3.43 |
| 2022-12-31 | $0.15B | $0.04B | 3.85 |
| 2022-09-30 | $0.14B | $0.03B | 4.27 |
| 2022-06-30 | $0.16B | $0.04B | 4.50 |
| 2022-03-31 | $0.11B | $0.04B | 3.01 |
| 2021-12-31 | $0.11B | $0.03B | 3.55 |
| 2021-09-30 | $0.13B | $0.03B | 4.10 |
| 2021-06-30 | $0.13B | $0.03B | 4.70 |
| 2021-03-31 | $0.13B | $0.03B | 5.17 |
| 2020-12-31 | $0.13B | $0.03B | 5.11 |
| 2020-09-30 | $0.13B | $0.02B | 6.65 |
| 2020-06-30 | $0.14B | $0.02B | 6.64 |
| 2020-03-31 | $0.15B | $0.02B | 6.59 |
| 2019-12-31 | $0.10B | $0.02B | 4.12 |
| 2019-09-30 | $0.10B | $0.02B | 4.81 |
| 2019-06-30 | $0.08B | $0.02B | 3.94 |
| 2019-03-31 | $0.09B | $0.02B | 5.54 |
| 2018-12-31 | $0.10B | $0.02B | 6.05 |
| 2018-09-30 | $0.11B | $0.02B | 7.06 |
| 2018-06-30 | $0.05B | $0.02B | 2.42 |
| 2018-03-31 | $0.04B | $0.02B | 1.99 |
| 2017-12-31 | $0.04B | $0.06B | 0.69 |
| 2017-09-30 | $0.00B | 0.00 | |
| 2017-06-30 | $0.00B | 0.00 | |
| 2017-03-31 | $0.00B | 0.00 | |
| 2016-12-31 | $0.01B | $0.06B | 0.23 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $1.421B | $0.165B |
| Establishment Labs Holdings Inc. is a medical technology company. It focuses on designing, developing, manufacturing and marketing portfolio of silicone gel-filled breast implants ae well as body shaping implants. The company's brand consists of Motiva Implants(R) and MotivaImagine (R) platform. Its technologies portfolio includes Divina 3D Simulation System(R), Puregraft and MotivaImagine Centers (R). Establishment Labs Holdings Inc. is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $117.972B | 15.31 |
| Cencora (COR) | United States | $47.529B | 18.97 |
| ICON (ICLR) | Ireland | $24.256B | 23.92 |
| DiDi Global (DIDIY) | China | $21.667B | 0.00 |
| Avantor (AVTR) | United States | $16.686B | 22.99 |
| Viatris (VTRS) | United States | $13.340B | 3.81 |
| CochLear (CHEOY) | $13.217B | 0.00 | |
| Revvity (RVTY) | United States | $12.387B | 21.57 |
| Charles River Laboratories (CRL) | United States | $11.968B | 21.82 |
| Medpace Holdings (MEDP) | United States | $11.930B | 43.36 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.918B | 0.00 |
| Natera (NTRA) | United States | $10.907B | 0.00 |
| Solventum (SOLV) | $10.687B | 0.00 | |
| Amplifon S.p.A (AMFPF) | Italy | $7.290B | 37.01 |
| HealthEquity (HQY) | United States | $6.887B | 51.46 |
| Bausch + Lomb (BLCO) | Canada | $4.944B | 19.01 |
| Doximity (DOCS) | United States | $4.675B | 34.81 |
| Organon (OGN) | United States | $4.548B | 4.40 |
| Progyny (PGNY) | United States | $3.209B | 53.85 |
| Surgery Partners (SGRY) | United States | $3.128B | 29.07 |
| Sotera Health (SHC) | United States | $3.083B | 15.12 |
| Life Times (LTH) | United States | $2.793B | 30.87 |
| GoodRx Holdings (GDRX) | United States | $2.575B | 130.40 |
| Premier (PINC) | United States | $2.480B | 9.08 |
| Teladoc Health (TDOC) | United States | $2.223B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $2.153B | 6.96 |
| Agilon Health (AGL) | United States | $1.835B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $1.809B | 0.00 |
| Agiliti (AGTI) | United States | $1.364B | 22.27 |
| NovoCure (NVCR) | Jersey | $1.341B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $0.926B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.750B | 7.76 |
| Embecta (EMBC) | United States | $0.596B | 3.94 |
| Auna S.A (AUNA) | Luxembourg | $0.562B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.556B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.544B | 0.00 |
| Enhabit (EHAB) | United States | $0.514B | 46.54 |
| MultiPlan (MPLN) | United States | $0.469B | 0.00 |
| Beauty Health (SKIN) | United States | $0.437B | 0.00 |
| CareDx (CDNA) | United States | $0.406B | 0.00 |
| LifeMD (LFMD) | United States | $0.400B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.366B | 0.00 |
| DocGo (DCGO) | United States | $0.340B | 54.33 |
| Sera Prognostics (SERA) | United States | $0.318B | 0.00 |
| ModivCare (MODV) | United States | $0.310B | 4.11 |
| Ascend Wellness Holdings (AAWH) | United States | $0.252B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.250B | 0.00 |
| Sharecare (SHCR) | United States | $0.240B | 0.00 |
| Biodesix (BDSX) | United States | $0.121B | 0.00 |
| So-Young (SY) | China | $0.114B | 38.17 |
| Oncology Institute (TOI) | United States | $0.086B | 0.00 |
| Pono Capital Two (PTWO) | United States | $0.063B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.059B | 0.00 |
| NeueHealth (NEUE) | United States | $0.049B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.039B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.037B | 0.00 |
| Nutex Health (NUTX) | United States | $0.034B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.029B | 0.00 |
| OncoCyte (OCX) | United States | $0.023B | 0.00 |
| DermTech (DMTK) | United States | $0.021B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.018B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| OpGen (OPGN) | United States | $0.006B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Assure Holdings (IONM) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |